RHINASTHMA-Adolescents: a new quality of life tool for patients with respiratory allergy by LA GRUTTA, S. et al.
ORIGINAL ARTICLE Asthma
RHINASTHMA-Adolescents: a new quality of life tool for
patients with respiratory allergy
Stefania La Grutta1,2, Massimo Landi3, Fulvio Braido4, Laura Montalbano1, Giuliana Ferrante1,2,
Velia Malizia2, Omar Fassio5, Giorgio W. Canonica4 & Ilaria Baiardini4
1Institute of Biomedicine and Molecular Immunology, National Research Council, Palermo, Italy; 2Department of Science for Health Promotion
and Mother and Child, University of Palermo, Palermo, Italy; 3National System of Pediatric Primary Care Asl TO 1, Turin, Italy; 4Allergy &
Respiratory Diseases Clinic – DIMI – University of Genoa, IRCCS AOU San Martino-IST, Genoa, Italy; 5Department of Psychology, Turin
University, Turin, Italy
To cite this article: La Grutta S, Landi M, Braido F, Montalbano L, Ferrante G, Malizia V, Fassio O, Canonica GW, Baiardini I. RHINASTHMA-Adolescents: a new
quality of life tool for patients with respiratory allergy. Pediatr Allergy Immunol 2014: 25: 450–455.
Keywords
adolescents; asthma; health-related quality of
life; rhinitis
Correspondence
Ilaria Baiardini, Allergy & Respiratory
Diseases Clinic – DIMI – University of Genoa,
IRCCS AOU San Martino-IST,
Pad. Maragliano, Largo Rosanna Benzi 10,
16132 Genova, Italy
Tel/Fax: +390105553524
E-mail: ilaria.baiardini@libero.it
Accepted for publication 22 April 2014
DOI:10.1111/pai.12242
Abstract
Background: Specific instruments for health-related quality of life (HRQoL) assessment
in adolescents with rhinoconjunctivitis or asthma are available. None of them evaluates
rhinitis and asthma together, although they often coexist. Our aim was to validate a
HRQoL questionnaire for adolescents with rhinoconjunctivitis, asthma, or both.
Methods: A pool of 38 items covering the main symptoms and problems related to
respiratory allergy was generated based on literature review, clinical experience, and
unstructured interviews to 54 adolescents. The items were randomly listed and
presented to 88 consecutive outpatients (44 M; mean age 15.2  3.1). Patients had to
indicate which item they had experienced and, for each selected item, its importance on
a four-point scale (1 = not at all; 4 = very much). Twelve items were excluded from
the list, because of low importance. In the validation phase, 102 patients (54 M; mean
age 15.36  1.12) completed the KINDL, a generic HRQoL tool, and the new
questionnaire (RHINASTHMA-Adolescents).
Results: Factor analysis revealed a five-dimensional structure, which explained up to
71.23% of the total variance. Association between RHINASTHMA-Adolescents and
KINDL scores was all in the expected direction. Internal consistency for the extracted
factors was satisfactory: Upper Airways (0.81), Lower Airways (0.89), Emotions
(0.85), Social Relationship (0.79), Daily life management (0.74). Reliability was good
for all factors with a Pearson coefficient ranged from 0.91 to 0.99.
Conclusions: RHINASTHMA-Adolescents is the first tool for evaluating HRQoL in
patients with rhinitis and/or asthma. It provides a simple assessment and met the
standards of validity, internal consistency, and reliability.
A critical aspect in the management of respiratory allergy is
its burden on patient’s health-related quality of life (HRQoL),
defined as the impact of a disease and its treatment perceived
by patients themselves (1). Health-related quality of life is
now recognized as a crucial outcome measure in patients
suffering from respiratory allergy. The use of questionnaires
to evaluate HRQoL is recommended by international guide-
lines (2, 3), specific recommendations for patient reported
outcomes assessment in rhinitis and asthma (4), and regula-
tory authorities (5, 6). Furthermore, the fundamental role of
patient’s perspectives is now underlined by the Grade of
Recommendations, Assessment Development and Evaluation
(GRADE) system (7), which represents the best option in
defining the criteria for grading evidence and developing
guidelines.
During the last years, several questionnaires were developed
and validated for measuring HRQoL in patients with rhinitis
or asthma, and some of these were specifically addressed for
children and adolescents (8–11). However, no one permits to
globally evaluate the burden of respiratory allergy when both
conditions are present.
Asthma frequently coexists with rhinitis being seen in half to
three quarter of children and teenagers with asthma in a range
of studies (12, 13).
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Patients with both rhinitis and asthma report a significant
impairment of their physical health, comorbid rhinitis, and
asthma resulting in an additional quality of life burden (14).
This observation is in line with the hypothesis of a common
pathogenic mechanism underlying rhinitis and asthma (‘united
airway disease’), suggesting that the assessment of HRQoL in
patients with respiratory allergy should consider both upper
and lower respiratory tract (15). The RHINASTHMA (15) is
the only available questionnaire designed to assess HRQoL in
comorbid asthma and allergic rhinitis, but it has been thought
for adult patients. For this reason, it is not adapted to capture
the impact of respiratory allergy in a transition phase like
adolescence (16). The presence of a chronic disease in teenagers
interferes with the physical, emotional, social, and cognitive
changes that are typical of this age. In particular, the need of
independence, the presence of intense emotions, the role of peer
group should be taken into account.
The aim of our study was to develop and validate a HRQoL
questionnaire for adolescents suffering from rhinitis and/or
asthma. As the RHINASTHMA, the new questionnaire
considers asthma and rhinitis as different aspects of the same
disease, so that the patient is not asked to attribute specific
symptoms or problems to asthma or rhinitis separately. The
new instrument takes into account the burden of symptoms
and problems experienced by adolescents with respiratory
allergy. This questionnaire was intended to be (1) short, simple,
and user-friendly, (2) psychometrically sound with good
validity and reliability, and (3) useful both in research and
clinical practice. The new questionnaire has been named
RHINASTHMA-Adolescents.
Methods
The development and validation of the new questionnaire
occurred in two separate phases (development procedure and
validation procedure) involving different groups of patients.
The method used for the two steps is described in detail below.
Patients
All adolescents recruited in the development and validation of
the new questionnaire were drawn from two Italian allergy
units. They suffered from respiratory allergy, ascertained
through the routine diagnostic procedure. In detail, all patients
underwent an interview for clinical and family history, clinical
visit, and skin prick test for the common allergens (a RAST
assay was also performed in selected cases). Rhinitis was
clinically diagnosed, according to ARIA guidelines (3). The
diagnosis of asthma was based on the presence of respiratory
symptoms such as cough, chest tightness, wheezing, acute
episodes of dyspnea, and the ascertainment of variable airway
obstruction by chest examination and spirometry, in agreement
with the GINA guidelines (2).
Development procedure
To ensure the inclusion of items appropriate and relevant for
adolescents with respiratory allergy, the generation and
selection of items, as well as item pretesting, were based on
current guidelines (17).
Item generation
The first task was to identify all those symptoms and problems,
which are perceived as relevant and troublesome by adolescent
suffering from with rhinoconjunctivitis, asthma, or both. First,
a pool of items was generated based on the following sources:
1 Recent literature review of the available HRQoL question-
naires and symptom score scales for rhinitis and asthma;
2 Discussion with expert allergists, pulmonologists, and
pediatricians; as a result, 26 relevant items were indicated;
3 Preliminary unstructured interviews to 54 adolescents with
respiratory allergy; an initial list of 30 expressions/items
was recognized, maintaining, whenever possible, the
patient’s expressions.
A qualitative selection was performed by eliminating those
items resulted redundant, ambiguous, difficult to understand,
expressed in negative form.
Item selection
The resulted list of 38 items was randomly listed and
administered to patients who had to indicate (i) which of the
items they have experienced (the response options were yes/no);
(ii) the importance of each selected item on a four-point scale
(1 = not at all; 4 = very much).
Patients were also asked to indicate other possible aspects on
which the respiratory allergy might impact and whatever they
consider worthy to be added or changed in the questionnaire.
This first phase was carried out in a sample of 90
outpatients, consecutively seen at our department over a
6-month period. We subsequently calculated: (i) the percentage
of patients who indicated each item as a consequence of their
disease (frequency range: 0–100), (ii) the importance (mean
value) attributed from the patient to each item indicated as a
problem (range: 0–4), and (iii) the overall importance score of
the item, defined as the product of the frequency and the mean
importance divided by 100 (range: 0–4).
The result of this first phase generated a 28-item question-
naire where patients had to indicate, on a Likert scale with
multiple options (1 = not at all, 5 = very much), how much
they were been troubled by each problem. The questionnaire
was then administered to a different patient population for
validation.
Validation procedure
The questionnaire obtained from the first phase was tested and
validated, in accordance with current guidelines, to assess the
following psychometric properties:
1 Validity. It assesses whether an instrument actually mea-
sures that which it was designed to measure. Two validation
analyses were designed: Factorial analysis was performed
on RHINASTHMA-Adolescents scores to identify poten-
tial subscales in accordance with our hypotheses; the
principal component method (Oblimin with Kaiser
Normalization) was adopted. By means of Pearson corre-
lation coefficients, we also assessed the relationship between
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the new questionnaire and the KINDL, to evaluate the
convergent validity. The KINDL (18, 19) is a generic
quality of life instruments that consists of 24 Likert-scaled
items associated with six dimensions: physical well-being,
emotional well-being, self-esteem, family, friends, and
school. The psychometric properties of this instrument in
adolescents with chronic disorders have been well docu-
mented (20, 21)
2 Internal consistency. It measures the homogeneity of a
scale. It was computed using Cronbach’s correlation
coefficient on the extracted factors. Measures with reliabil-
ity of 0.50–0.70 or greater have been recommended for the
purpose of comparing group (22).
3 Reliability. It refers to the degree to which an instrument
yields stable scores over a short period of time, assuming
there is no clinical change. Reliability was assessed by
administering RHINASTHMA-Adolescents to 38 stable
patients at baseline and after 1 week. Data were analyzed
by t-test for paired samples as recommended in statistical
literature (22).
4 Responsiveness. It measures the ability of the questionnaire
to detect significant differences over time in patients whose
status has changed. Responsiveness was evaluated in a group
of 30 patients at baseline and after 15/21 days of treatment in
accordance with ARIA and GINA guidelines and reporting
diminished symptoms. The RHINASTHMA-Adolescents
scores were compared by a nonparametric test (Wilcoxon)
5 Floor and ceiling effects. These measurements are per-
formed to ensure that a score had the ability to cover the
full range of severity for the considered scale and permits to
identify the subjects at the extremes of the scale. Such
effects were considered to be present if more than 15% of
the patients in a sample of at least 50 patients achieved the
lowest or highest possible scores, respectively (23).
The local ethics committee approved the study, and partic-
ipating subjects gave their written informed consent.
Results
Development procedure
Of 90 patients, 88 completed the preliminary questionnaire, 47
females and 41 males; the mean age was 15.2  3.1 with range
of 12–18. On the basis of patients’ answers, items included in
the questionnaire were those that scored highest in impact.
Where an arbitrary cutoff value of 1.5 was used for impact, 10
items were excluded. Table 1 summarizes the results of this first
phase, indicating the items removed due to the low total
importance.
Validation procedure
Of 105 patients, 102 filled in both RHINASTHMA-Adoles-
cents and KINDL. The assessment of data missing from
completed questionnaire was very small (1.94%). Filling in the
questionnaire took, on the average, 6 min (and in no case,
more than 8 min). Table 2 summarizes sample’s demographic
and clinic characteristics.
Table 1 Development procedure: results of item selection
(88 patients)
Item
Frequency
(%)
Mean
importance
Overall
Impact
Does asthma/rhinitis affect
your school activities?
44.2 2.1 0.9
I felt nervous 58.4 3.1 1.8
I had difficulties in falling
asleep
31.2 1.9 0.6
I had the feeling of not being
able to control the symptoms
39.8 2.3 0.9
I felt stressed out by my parents 73.8 2.8 2.1
I had wheezing 61.5 3.1 1.9
I felt ashamed 30.9 2.5 0.8
I had difficulties in concentrating 53.4 3.1 1.6
I had difficulties in breathing 71.3 2.9 2.1
I realized I was not able to do
everything that I wanted
68.4 3.3 2.3
I stayed at home 21.9 2.3 0.5
I had difficulties in doing sports 49.4 3.7 1.83
I had chest tightness 55.6 2.8 1.6
I had to avoid
certain environments
44.7 3.8 1.7
I felt different from my peers 78.3 2.4 1.9
I felt uncomfortable 81.4 3.1 2.5
I was afraid of being sick 59.8 2.7 1.6
I made less than I wanted 38.3 2.2 0.8
It bothered me having to do
medical checks
71.5 2.7 1.9
I had the cough 56.3 3.1 1.8
I slept badly 58.9 2.7 1.6
I felt sad 61.4 3.2 1.9
It bothered me having to take
drugs
81.9 2.6 2.1
I had stuffy nose 68.2 3.4 2.3
I often had to clear my throat 17.3 2.1 0.4
I felt anxious when did not have
medicines with me
49.3 3.3 1.6
I had red/watery eyes 53.4 2.9 1.6
I woke up in the night 44.3 2.1 0.9
I felt unlucky 31.3 3.2 1
It bothered me having to always
have handkerchiefs in my
pocket
59.2 2.7 1.6
I felt angry 66.3 2.4 1.6
I felt limited in my social
life (parties,
trips, relationships with friends)
73.2 2.3 1.7
I had sneezing 73.1 2.5 1.8
The medications that I take gave
me annoying side effects
54.3 3.1 1.7
I had difficulty telling others
that I suffer from asthma
and/or rhinitis
33.1 1.9 0.6
I had shortness of breath 53.2 3.3 1.8
I had difficulty hearing odors 61.3 2.7 1.7
I had a runny nose 63.4 3.2 2
Boldfaces indicate low-important items (overall impact <1.5).
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1 Validity. Factor analysis revealed a five-dimensional struc-
ture, which explained up to 71.23% of the total variance
(Table 3). Eight items were excluded because they were not
allocated in the extracted dimension (I had difficulties in
concentrating; I had to avoid certain environments; I felt
uncomfortable; I had the cough; I slept badly; I had red/
watery eyes; It bothered me having to always have
handkerchiefs in my pocket). This solution was deemed
appropriate on the basis of eigenvalues. Association
between RHINASTHMA-Adolescents and KINDL scores
was all in the expected direction: as showed in Table 4,
conceptually similar domains had higher correlations than
conceptually unrelated domains.
2 Internal consistency. Internal consistency reliability for the
extracted factors exceeded the minimum reliability standard
of 0.50–0.70. In fact all the dimensions showed satisfactory
Cronbach’s alpha values: Upper Airways (0.81), Lower
Airways (0.89), Emotions (0.85), Social Relationship (0.79),
Daily life management (0.74).
3 Reliability. The RHINASTHMA-Adolescents was com-
pleted twice by 38 patients (20 males and 18 females) with a
mean (SD) age of 41 (14.6) years. All factors showed a
good stability: the Pearson coefficient ranged from 0.91 to
0.99.
4 Responsiveness. All RHINASTHMA–Adolescents factors
showed a good responsiveness: Upper Airways (p = 0.003),
Lower Airways, (p = 0.01), Emotions (p = 0.006), Social
Relationship (p = 0.02), Daily life management
(p = 0.004), testifying that the questionnaire is responsive
in health changes.
5 Floor and ceiling effects. 7% and 9% of allergic patients
reported the minimal (highest HRQoL) or maximal (lowest
HRQoL) score in each of the domains in the questionnaire
indicating minimal floor and ceiling effects.
Discussion
This psychometric testing of the RHINASTHMA-Adolescents
provides evidence that the new questionnaire appropriately
Table 2 Validation procedure: sample’s demographic and clinical
characteristics (n = 102)
Demographic characteristics
Sex, n (%)
Males 54 (52.9%)
Females 48 (47.1%)
Age, yrs (mean  SD) 15.36  1.12
Rhinitis
Intermittent 39 (38.2%)
Persistent 63 (61.8%)
Asthma
Intermittent 54 (59.2%)
Persistent 48 (47.15)
Smoking
Smokers 12 (11.8%)
Non-smoker 90 (88.2%)
Table 3 Factors identified using principal components analysis on full data set (bold 2 typeface shows the component upon which each item
loaded most highly)
Factor 1 Factor 2 Factor 3 Factor 4 Factor 5
Lower airways Emotions
Social
Relationship
Daily life
management
Upper
airways
I had difficulties in breathing 0.903 0.218 0.178 0.318 0.371
I had shortness of breath 0.851 0.243 0.173 0.436 0.345
I had wheezing 0.844 0.262 0.375 0.080 0.445
I had chest tightness 0.643 0.157 0.371 0.456 0.402
It bothered me having to do medical checks 0.371 0.913 0.232 0.052 0.241
I felt nervous 0.046 0.853 0.251 0.149 0.255
I felt angry 0.415 0.697 0.336 0.086 0.325
It bothered me having to take drugs 0.059 0.634 0.352 0.212 0.339
I felt different from my peers 0.165 0.261 0.822 0.221 0.285
I felt limited in my social life (parties, trips,
relationships with friends)
0.287 0.171 0.703 0.279 0.189
The medications that I take gave me annoying
side effects
0.235 0.258 0.653 0.019 0.340
I was afraid of being sick 0.025 0.212 0.652 0.088 0.318
I felt sad 0.179 0.192 0.296 0.776 0.157
I felt stressed out by my parents 0.338 0.444 0.147 0.659 0.216
I had difficulties in doing sports 0.344 0.027 0.171 0.602 0.238
I realized I was not able to do everything that I wanted 0.497 0.145 0.275 0.553 0.406
I had stuffy nose 0.397 0.256 0.205 0.313 0.804
I had a runny nose 0.267 0.284 0.348 0.302 0.769
I had sneezing 0.243 0.293 0.317 0.181 0.708
I had difficulty hearing odors 0.393 0.078 0.436 0.071 0.623
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explores HRQoL in adolescents suffering from respiratory
allergy. As described in the development procedure, it includes
items that have been chosen directly by the patients and are
consequently relevant to them. Furthermore, the validation
process shows that the questionnaire met the standards
for validity, internal consistency, and reliability. The RHI-
NASTHMA-Adolescents is a 20-item tool that is simple, easy
to administer, and requires a few minutes to complete without
any assistance. These psychometric characteristics make the
RHINASTHMA-Adolescents useful to evaluate the specific
burden of rhinitis and/or asthma on HRQoL.
The global care of patients includes clinical and instru-
mental parameters together with the evaluation of their
HRQoL. This is especially significant in patients suffering
from chronic diseases. In fact, the presence of a chronic
condition results in physical, emotional, and relational prob-
lems that may impact patient’s HRQoL as well as their
caregivers (23). For this reason, it is particularly important to
achieve a subjective description of the impact of the disease
on patient’s everyday life (4). It is well known that more than
50% of subjects with rhinitis also suffer from asthma and
almost 90% of asthmatic patients also have allergic rhinitis
(24, 25). In addition, the finding of 20% of RC prevalence
(17.9% as a single condition and 2.1% in association with
current asthma) was found in an epidemiologic survey on
adolescents living in Southern Italy (26). Patients with both
rhinitis and asthma report a significant impairment of their
physical health, comorbid rhinitis, and asthma resulting in an
additional quality of life burden (14). This observation is in
line with the hypothesis of a common pathogenic mechanism
underlying rhinitis and asthma (‘united airway disease’),
suggesting that the assessment of HRQoL in patients with
respiratory allergy should consider both upper and lower
respiratory tract. However, during past years, asthma and
rhinitis were considered as distinct diseases, and their impact
on quality of life has been studied by specific questionnaires
addressed to one disease or the other (15).
At present, only a questionnaire, the RHINASTHMA,
developed in Italian, permits to obtain an evaluation of the
overall impact of these diseases on HRQoL. This tool has been
validated for adults. For this reason, we developed a new
questionnaire, specifically addressed to adolescents, suitable
for patients suffering from respiratory allergy, independent of
their disease (rhinitis or asthma) (15).
The validation of a questionnaire is an iterative process, and
this study may be considered the first phase of that process.
Further work is planned on the relationship of the RHI-
NASTHMA-Adolescents to other clinical features (i.e., disease
severity, atopy degree, anxiety, depression) and psychologic
characteristics (coping ability, alexithymia).
The use of questionnaires to assess HRQoL is today
recommended by international guidelines (2, 3) and regulatory
authorities for the evaluation of new drugs (5, 6). Furthermore,
the fundamental role of patient’s perspectives is underlined by
the GRADE system (7), which represents the best option in
defining the criteria for grading evidence and developing
guidelines. The RHINASTHMA-Adolescents questionnaire is
able to discriminate the disease severity level, it is sensitive for
individual changes, and it is simple to administer, giving an
immediate idea of the burden of the disease in patient’s
everyday life (23). In this context, the RHINASTHMA-
Adolescents could be useful as in clinical trial as in routine
medical practice to better manage respiratory allergy in
adolescents.
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